Echo Street Capital Management LLC Catalent, Inc. Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $812,602 - $1.27 Million	11,230 New	11,230 $813,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $846,673 - $1.12 Million	-8,989 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $1.07 Million - $1.25 Million	8,989 New	8,989 $1.15 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1.01 Million - $1.31 Million	-9,222 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $925,335 - $1.07 Million	9,222 New	9,222 $997,000
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $1.18 Million - $1.5 Million	-16,221 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $778,932 - $1.28 Million	16,221 New	16,221 $1.19 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.